Bruce Thornton serves as Executive at Sonoma Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Bruce Thornton has executed 2 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jun 20, 2024 involved receiving (via award) 53,586 shares valued at $0.
Bruce Thornton currently holds 154,411 shares of Sonoma Pharmaceuticals, Inc. (SNOA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Bruce Thornton has been a net neutral trader of SNOA stock. They have purchased $0 and sold $0 worth of shares.
Bruce Thornton's most recent insider trade was on Jun 20, 2024, when they sold 53,586 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |